Malignant thymoma: Current status and future directions

Cancer Treatment Reviews

Volumn 26, Issue 2, 2000, Pages 127-131

  Lara Jr , N P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LANTREOTIDE; OCTREOTIDE; PREDNISONE; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; VINCRISTINE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ERYTHROCYTE APLASIA; HISTOLOGY; HUMAN; HYPOGAMMAGLOBULINEMIA; MEDIASTINUM; METASTASIS; MYASTHENIA GRAVIS; PARANEOPLASTIC SYNDROME; PROGNOSIS; RECURRENT CANCER; REVIEW; THYMOMA;

EID: 0342424736     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.1999.0159     Document Type: Review

References (37)

1. Morgenthaler T., Brown L., Colby T. Thymoma. Mayo Clin Proc. 68:1993;1110-1123.
2. McKenna W. G., Bonomi P., Barnes M. M., and Glatstein E. Malignancies of the thymus. Roth J. A., Ruckdeschel J. C., Weisenburger T. H. Thoracic oncology. 1989;466-477 WB Saunders Co, Philadelphia, PA.
3. Fornasiero A., Daniele O., Ghiotto C. Chemotherapy of invasive thymoma. J Clin Oncol. 8:1990;1419-1423.
4. Wilkins E. W., Grillo H., Scannell G. Role of staging in prognosis and management of thymoma. Ann Thorac Surg. 51:1991;888-892.
5. Halpern S. R., Schoelzel E., Johnson R. B. Thymoma in a young child producing symptoms of asthma. Am J Dis Child. 111:1966;99-104.
6. Pescarmona E., Rendina E. A., Venuta F. Analysis of prognostic factors and clinicopathologic staging of thymoma. Ann Thorac Surg. 50:1990;534-538.
7. Blumberg D., Port J., Weksler B. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 60:1995;908-914.
8. Osserman K. E., Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 38:1971;497-537.
9. Rosenow E. C., Hurley B. T. Disorders of the thymus: a review. Arch Intern Med. 144:1984;763-770.
10. McKenna W. G., Bonomi P. D., Barnes M. M., Glatstein E. Malignancies of the thymus. Roth J. A., Rucksdeschel J. C., Weisenburger T. H. Thoracic Oncology. 1989;466-477 WB Saunders, Philadelphia PA.
11. Muller-Hermelink H. K., Marino M., Palestro G. Pathology of thymic epithelial tumors. Curr Topics Pathol. 75:1986;207-268.
12. Schneider P. M., Fellbaum C., Fink U. Prognostic importance of histomorphic subclassification for epithelial thymic tumors. Ann Surg Oncol. 4:1997;46-56.
13. Masaoka A., Monden Y., Nakahara K. Follow-up study of thymoma with special reference to their clinical stages. Cancer. 48:1981;2485-2492.
14. Cooper J. D. Current therapy for thymoma. Chest. 103:1993;334S-336S.
15. Tomiak E. M., Evans W. K. The role of chemotherapy in invasive thymoma: a review of the literature and considerations for future clinical trials. Crit Rev Oncol Hematol. 15:1993;113-124.
16. Loehrer P. J. Thymomas: curent experience and future directions in therapy. Drugs. 45:1993;477-487.
17. Fechner R. E. Recurrence of non-invasive thymomas. Cancer. 23:1969;1423-1427.
18. Maggi G., Casadio C., Cavallo A. Thymoma: results of 241 operated cases. Ann Thorac Surg. 51:1991;152-156.
19. Nakahara K., Ohno K., Hashimoto J. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovac Surg. 95:1988;1041-1047.
20. Curran W. J., Kornstein M. J., Brooks J. J., and Turrisi A. T. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 6:1988;1722-1727.
21. Lava N., Rodichok I., and Martinez L. Recurrence of thymoma and myasthenia gravis after 19 years - a case report. Neurology. 26:1976;696-698.
22. Denayer M. A., Rao K. R., Wirz D., and McNally D. Hepatic metastatic thymoma and myasthenia gravis twenty-two years after the apparent cure of an invasive thymoma. J Neurol Sci. 76:1986;23-30.
23. Ariaratnam L., Kalnicki S., Mincer F. The management of malignant thymoma with radiation therapy. Int J Radiat Oncol Biol Phys. 5:1979;77-80.
24. Haniuda M., Morimoto M., Nishimura H. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg. 54:1992;311-315.
25. Wang L., Huang M., Lin T. Malignant thymoma. Cancer. 70:1992;443-450.
26. Boston B. Chemotherapy of invasive thymoma. Cancer. 38:1976;49-52.
27. Bonomi P. D., Finkelstein D., Aisner S. EST 2582: Phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol. 16:1993;342-345.
28. Highley M. S., Underhill C. R., Parnis F. X. Treatment of invasive thymoma with single agent ifosfamide. J Clin Oncol. 17:1999;2737-2744.
29. Fornasiero A., Daniele O., Ghiotto C. Chemotherapy for invasive thymoma: a 13-year experience. Cancer. 68:1991;30-33.
30. Loehrer P. J., Kim K., Aisner S. Cisplatin plus doxorubicin plus cyclophophamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol. 12:1994;1164-1168.
31. Oshita F., Kasai T., Kurata T. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results. Jpn J Clin Oncol. 25:1995;208-212.
32. Giaccone G., Ardizoni A., Kirkpatrick A. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 14:1996;814-820.
33. Loehrer P. J., Jiroutek M., Aisner S. et al. Phase II trial of etoposide (V), ifosfamide (I), plus cisplatin (P) in patients with advanced thymoma (T) or thymic carcinoma (TC): preliminary results from an ECOG coordinated intergroup trial. Proc Am Soc Clin Oncol. 17:1998;118.
34. Palmieri G., Lastoria S., Montella L. Phase II study of somatostatin analogs and prednisone in chemotherapy-refractory thymoma patients. Proc Am Soc Clin Oncol. 18:1999;448a (#1730).
35. Lara P. N., Bonomi P. D., Faber L. P. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide. Chest. 110:1996;1115-1117.
36. Musi M., Di Vito F., Rosti G. Salvage chemotherapy for recurrent invasive thymoma (letter). Chest. 112:1997;572.
37. Gerbino A., Berutti A., Gorzegno G. Neoadjuvant chemotherapy with doxorubicin, cisplatin, vincristine and cyclophosphamide (ADOC) in locally advanced thymoma. Proc Am Soc Clin Oncol. 17:1998;1867.